Intensive studies have revealed that there is a variety of abnormal expression patterns of lncRNAs in various tissues under insulin-resistant status, and dysregulated lncRNA profiles are associated with metabolic diseases including diabetes and nonalcoholic steatohepatitis (NASH) [14,15,16]. The gene discussed is INS; the disease is metabolic dysfunction-associated steatohepatitis.